View in EDS

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
Authors: Camidge DR; University of Colorado Cancer Center, Aurora, CO., Barlesi F; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Inserm U911 CRO2, Marseille, France.; Medical Oncology Department, Gustave Roussy, Villejuif, France., Goldman JW; David Geffen School of Medicine at UCLA, Los Angeles, CA., Morgensztern D; Washington University School of Medicine, St Louis, MO., Heist R; Massachusetts General Hospital Cancer Center, Boston, MA., Vokes E; University of Chicago Medicine, Chicago, IL., Spira A; Virginia Cancer Specialists Research Institute, Fairfax, VA., Angevin E; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France., Su WC; National Cheng Kung University Hospital, Tainan, Taiwan., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, TX., Strickler JH; Duke University Medical Center, Durham, NC., Motwani M; AbbVie Inc, North Chicago, IL., Dunbar M; AbbVie Inc, North Chicago, IL., Parikh A; AbbVie Inc, Redwood City, CA., Noon E; AbbVie Inc, North Chicago, IL., Blot V; AbbVie Inc, North Chicago, IL., Wu J; AbbVie Inc, North Chicago, IL., Kelly K; University of California Davis Comprehensive Cancer Center, Sacramento, CA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 10; Vol. 41 (5), pp. 1105-1115. Date of Electronic Publication: 2022 Oct 26.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36288547
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; University of Colorado Cancer Center, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Barlesi+F%22">Barlesi F</searchLink>; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Inserm U911 CRO2, Marseille, France.; Medical Oncology Department, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Goldman+JW%22">Goldman JW</searchLink>; David Geffen School of Medicine at UCLA, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Morgensztern+D%22">Morgensztern D</searchLink>; Washington University School of Medicine, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Heist+R%22">Heist R</searchLink>; Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Vokes+E%22">Vokes E</searchLink>; University of Chicago Medicine, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Spira+A%22">Spira A</searchLink>; Virginia Cancer Specialists Research Institute, Fairfax, VA.<br /><searchLink fieldCode="AU" term="%22Angevin+E%22">Angevin E</searchLink>; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Su+WC%22">Su WC</searchLink>; National Cheng Kung University Hospital, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hong+DS%22">Hong DS</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Strickler+JH%22">Strickler JH</searchLink>; Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Motwani+M%22">Motwani M</searchLink>; AbbVie Inc, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Dunbar+M%22">Dunbar M</searchLink>; AbbVie Inc, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Parikh+A%22">Parikh A</searchLink>; AbbVie Inc, Redwood City, CA.<br /><searchLink fieldCode="AU" term="%22Noon+E%22">Noon E</searchLink>; AbbVie Inc, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Blot+V%22">Blot V</searchLink>; AbbVie Inc, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; AbbVie Inc, North Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Kelly+K%22">Kelly K</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2023 Feb 10; Vol. 41 (5), pp. 1105-1115. <i>Date of Electronic Publication: </i>2022 Oct 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36288547
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.22.00739
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1105
    Titles:
      – TitleFull: Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Camidge DR
      – PersonEntity:
          Name:
            NameFull: Barlesi F
      – PersonEntity:
          Name:
            NameFull: Goldman JW
      – PersonEntity:
          Name:
            NameFull: Morgensztern D
      – PersonEntity:
          Name:
            NameFull: Heist R
      – PersonEntity:
          Name:
            NameFull: Vokes E
      – PersonEntity:
          Name:
            NameFull: Spira A
      – PersonEntity:
          Name:
            NameFull: Angevin E
      – PersonEntity:
          Name:
            NameFull: Su WC
      – PersonEntity:
          Name:
            NameFull: Hong DS
      – PersonEntity:
          Name:
            NameFull: Strickler JH
      – PersonEntity:
          Name:
            NameFull: Motwani M
      – PersonEntity:
          Name:
            NameFull: Dunbar M
      – PersonEntity:
          Name:
            NameFull: Parikh A
      – PersonEntity:
          Name:
            NameFull: Noon E
      – PersonEntity:
          Name:
            NameFull: Blot V
      – PersonEntity:
          Name:
            NameFull: Wu J
      – PersonEntity:
          Name:
            NameFull: Kelly K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 02
              Text: 2023 Feb 10
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1